No. 25-2, July 2022
Index
- A critical evaluation of the interface between intellectual property rights and human rights with special emphasis on indigenous intellectual property
- A potential intellectual property issue with the way in which some nomenclature code decisions are made
- Biodiversity and intellectual property rights: Conflict or synergy
- Book commentary: ‘The Protection of Intellectual Property Rights under International Investment Law Simon Klopschinski, Christopher S. Gibson, Henning Grosse Ruse Khan, OUP, Oxford, 2021
- Ethical and legal balance of modern economic intelligence
- Historical account of dwindling national flexibilities from the Paris Convention to post‐TRIPS era: What implications for access‐to‐medicines in low‐and‐middle‐income‐countries?
- Internet of Things and the Law: Legal Strategies for Consumer‐Centric Smart Technologies Guido Noto la Diega (Routledge 2022, 416 pages)
- Issue Information
- Patent as security in insolvency process: Problems and solutions
- Patent law and 3D printing applications in response to COVID‐19: Exceptions to inventor rights
- Patent law failure: A systematic literature review
- Patent power in biomedical innovation: Technology governance in biomodifying technologies
- Role of traditional knowledge in the COVID‐19 battle
- Software protection and software piracy
- Stewardship or ownership in India: Options for community seed banks in managing crop genetic resources in relation to intellectual property rights
- Streaming platforms under Portuguese copyright law
- The COVID‐19 pandemic and long‐term incentives for developing vaccines: Patent law under stress
- The legal protection of new plant varieties in Algerian and American system
- Treasured relations: Towards partnership and the protection of Māori relationships with taonga plants in Aotearoa New Zealand
- US anti‐suit injunctions and German anti‐anti‐suit injunctions in SEP disputes
- Using the flexibilities of Article 30 TRIPS to implement patent exceptions in pursuit of Sustainable Development Goal 3
- What determines foreign direct investment to India's pharmaceutical sector? Intellectual property implementation versus inherent institutional strength